75000 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 75010 - Statement - Condensed Consolidated Balance Sheets (unaudited) link:presentationLink link:calculationLink link:definitionLink 75020 - Statement - Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 75030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) link:presentationLink link:calculationLink link:definitionLink 75040 - Statement - Condensed Statements of Stockholders' Equity (unaudited) link:presentationLink link:calculationLink link:definitionLink 75050 - Statement - Condensed Consolidated Statements of Cash Flows (unaudited) link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Organization and Description of the Business link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Basis of Presentation and Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Other Financial Statement Information link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Cash, Cash Equivalents and Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Licenses And Intangible Assets link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Stock Compensation link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Other Financial Statement Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Licenses And Intangible Assets (Table) link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Notes Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Stock Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Organization and Description of the Business - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Basis of Presentation and Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Other Financial Statement Information - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Other Financial Statement Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Other Financial Statement Information - Schedule of Prepaid Expenses and Other Current Assets (Details) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Other Financial Statement Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Summarizes the Unrealized Gains and Losses in Fair Value of the Company's Investments in Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Cash, Cash Equivalents And Marketable Securities - Schedule of Estimated Fair Value of Marketable Securities by Stated Contractual Maturities (Details) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Licenses And Intangible Assets - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Licenses And Intangible Assets - Summary of Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Licenses And Intangible Assets - Summary of Estimated Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Notes Payable - Schedule of Notes Payable (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Notes Payable - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Notes Payable - Schedule Principal Installments Due (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Stockholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Stock Compensation - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Stock Compensation - Summary of Company's Equity Plans (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Stock Compensation - Summary of Share-based Compensation Arrangements by Share-based Payment Award (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Stock Compensation - Summary of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Stock Compensation - Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Stock Compensation - Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount (Details) [Default] link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Stock Compensation - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Commitments and Contingencies - Schedule of Minimum Purchase Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Summary of Dilutive Shares Excluded from Computation of Diluted Net Loss Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Segment Reporting - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Segment Reporting - Schedule of Segment Operating Expenses Including Segment Expenses, and Net Loss (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Segment Reporting - Schedule of Segment Operating Expenses Including Segment Expenses, and Net Loss (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink Related Party Transaction [Table] Basis of Presentation and Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Proceeds from maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Amount of Allocation To Noncurrent Deferred Finance Cost Amount of allocation to noncurrent deferred finance cost. Allocation to noncurrent deferred finance cost Share based compensation, Nonvested awards, Compensation cost not yet recognized Stock options and equity instruments other than options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total Payment of Deferred Issuance Costs Related to Unfunded Loan Commitments Payment of deferred issuance costs related to unfunded loan commitments Payment of deferred issuance costs related to unfunded loan commitments Purchase Obligation Total minimum purchase obligations Operating Lease, Right-of-Use Asset, Periodic Reduction Reduction in the carrying amount of operating lease right-of-use assets Cash dividends Dividends, Cash Dividends, Cash, Total Long-Term Debt, Maturity, Year Three 2029 Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Two Thousand and Twenty One Employee Stock Purchase Plan [Member] Two thousand and twenty one employee stock purchase plan. 2021 Employee Stock Purchase Plan [Member] Market Capitalization Threshold Amount Invalidating the Loan Coverage Ratio Market capitalization threshold amount which invalidates loan coverage ratio upon condition. Market capitalization threshold amount invalidating the loan coverage ratio Minimum [Member] Minimum [Member] Grantee Status [Axis] Robert Brenner [Member] Robert Brenner. Robert Brenner [Member] Issuance of common stock upon vesting of restricted stock units, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Long-Term Debt, Maturity, Year Two 2028 Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Collateralized note, Effective interest rate Ares Agreement Member Ares Agreement [Member] Ares Agreement [Member] Common stock, Shares issued Common Stock, Shares, Issued Common Stock, Shares, Issued, Total Shares issued pursuant to ESPP Segment Reporting [Line Items] Schedule Of Share Based Payment Award Stock Options Valuation Assumptions [Line Items] Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Other Expenses Other segment items* Debt Instrument, Face Amount Maximum available capacity Intangible Assets, Net Intangible Assets, Finite-Lived, Policy [Policy Text Block] Counterparty Name [Domain] Related Party Transaction [Line Items] Restricted Stock Units R S U [Member] Restricted Stock Units (RSUs) [Member] Operating Segments [Member] Operating Segments [Member] Intangible Asset, Finite-Lived, Class [Domain] Line of Credit Facility, Maximum Borrowing Capacity Revolving credit facility with borrowing capacity Credit facility, Maximum amount drew Amount Of Allocation To Discount On Note Payable Amount of allocation to discount on note payable. Reduction to the net carrying amount Estimated Fair Value Cash Equivalent And Marketable Securities Cash equivalent and marketable securities. Debt Securities, Available-for-sale, Amortized Cost, Total Debt Securities, Available-for-Sale, Amortized Cost Amortized Cost Subsequent Event Type [Domain] Increase (Decrease) in Other Current Assets Other assets Other assets Other Comprehensive Income (Loss), before Tax [Abstract] Other comprehensive loss: One Month CME Term Secured Overnight Financing Rate [Member] One month CME term secured overnight financing rate. 1-Month CME Term SOFR [Member] Cash And Cash Equivalents And Marketable Securities Cash And Cash Equivalents And Marketable Securities Cash and cash equivalents and marketable securities Nonoperating Income (Expense) Total other income, net Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised, Total Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised Proceeds from exercise of stock options and employee stock purchase plan Schedule of Long-Term Debt Instruments [Table] Costs and Expenses, Related Party Fees and expenses Unrealized Losses Debt Securities, Availablen for Sale, Gross Unrealized Loss Debt securities, availablen for sale, gross unrealized loss. Income Statement [Abstract] Cancelled and forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Cancelled and forfeited Percentage Of Exit Fee On Old Debt Principal Amount Percentage Of Exit Fee On Old Debt Principal Amount Percentage of exit fee on old debt principal amount Related and Nonrelated Parties [Domain] Vesting [Axis] Intangible Asset, Finite-Lived [Table] Net loss per share attributable to common stockholders, basic Earnings Per Share, Basic Earnings Per Share, Basic, Total Document Period End Date 2026 (remaining) Intangible Asset, Finite-Lived, Estimated Amortization Expense, Remainder of Fiscal Year Document Information [Table] Intangible Asset, Finite-Lived, after Accumulated Amortization Intangible Asset, Finite-Lived, after Accumulated Amortization, Ending Balance Intangible Asset, Finite-Lived, after Accumulated Amortization, Beginning Balance Net Carrying Amount Total estimated future amortization expense Proceeds from Debt, Net of Issuance Costs Net cash proceeds Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration period Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Payments to Acquire Property, Plant, and Equipment, Total Debt Instrument [Line Items] Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Granted Common stock, shares authorized Common stock, Shares authorized Common Stock, Shares Authorized Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Two 2028 Debt Issuance Costs Paid To Creditors Debt issuance costs paid to creditors. Debt issuance costs paid to creditors Statement of Stockholders' Equity [Abstract] Share based compensation by share based payment options non vested forfeitures in period weighted average exercise price. Share Based Compensation By Share Based Payment Options Non Vested Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price, Cancelled and forfeited Prepaid Expense and Other Assets, Current Total prepaid expenses and other current assets Prepaid expenses and other assets, current Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block] Summary of Company's Equity Plans Purchase Obligation, to be Paid, Year One 2027 Investments [Domain] Nominal interest rate Debt Instrument, Interest Rate, Stated Percentage Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Common Class B [Member] Common Class B [Member] Aggregate Intrinsic Value, Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Supplemental disclosure of cash flow information Supplemental Cash Flow Elements [Abstract] Total assets Assets Title of 12(b) Security Cash and cash equivalents [Member] Cash and Cash Equivalents [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unvested, Beginning balance Unvested, Ending balance Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock pursuant to exercise of options, value Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of Options, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Issuance of common stock pursuant to exercise of options Customer Concentration Risk [Member] Antidilutive Securities, Name [Domain] Two Thousand And Seventeen And Two Thousand And Twenty One Amended Equity incentive Plan [Member] Two Thousand And Seventeen And Two Thousand And Twenty One Amended Equity incentive Plan. 2021 and 2017 Amended Equity Incentive Plan [Member] License and Intangible Assets [Text Block] The entire disclosure for license and intangible assets. Licenses And Intangible Assets Variable Rate [Axis] Cash paid for interest expense Interest Paid, Excluding Capitalized Interest, Operating Activity London Interbank Offered Rate Member London Interbank Offered Rate [Member] LIBOR [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Weighted-Average Remaining Contractual Life Organization and Description of the Business Nature of Operations [Text Block] Prepaid Clinical Trial Costs Prepaid clinical trial costs Prepaid clinical trial costs. Operating lease liabilities Increase (Decrease) in Operating Lease Liability Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Four 2030 Internal-Use Software License Acquired Through Accrued Liabilties Internal-Use Software License Acquired Through Accrued Liabilties Internal-use software license acquired through accrued liabilities Beginning Balances, Value Ending Balances, Value Equity, Attributable to Parent Total stockholders' equity Entity Address, Address Line Two No Other Individual Customers [Member] No other individual customers. Other Assets, Noncurrent Other assets, noncurrent Total other noncurrent assets Earnings Per Share [Text Block] Net Loss Per Share Attributable to Common Stockholders Due within one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Prepaid Drug Manufacturing Costs Prepaid drug manufacturing costs. Prepaid drug manufacturing costs Number of Reportable Segments Number of reportable segments Stockholders' Equity Note [Abstract] Revenue Benchmark [Member] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Long-Term Debt Long-term debt Net carrying amount of debt Credit Facility [Axis] Stock, Class of Stock [Table] Inventory, Policy [Policy Text Block] Inventory Restricted Stock [Member] Restricted Stock [Member] Tranche D [Member] Tranche D Member. Tranche C [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Vested Unvested restricted stock units. Unvested Restricted Stock Units [Member] Unvested Restricted Stock Units Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year Three 2029 Event Event [Axis] Event [Axis] Purchase Of Internal Use Software License Purchase Of Internal Use Software License Purchase of internal use software license Schedule of Maturities of Long-Term Debt [Table Text Block] Schedule Principal Installments Due Statistical Measurement [Axis] Upfront and milestone obligations under license agreements Upfront And Milestone Obligations Under License Agreements Upfront And Milestone Obligations Under License Agreements Money Market Funds [Member] Money Market Funds [Member] Amount Of Debt Available On Achievements On milestones Amount of debt available on achievements on milestones. Amount of debt available on achievements on milestones Entity Interactive Data Current Expected volatility, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Prepaid Software Costs Prepaid Software Costs Prepaid software costs Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones Reach Two Fifty Million [Member] Achievement of specified worldwide aggregate annual net sales milestones reach two fifty million. Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones Reach Two Fifty Million [Member] Weighted Average Remaining Contractual Life, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Class A common stock, $0.001 par value; 500,000,000 shares authorized as of September 30, 2026 and December 31, 2025; 72,287,904 and 71,267,429 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Inventory [Line Items] US Government Agencies Debt Securities [Member] U.S. Government Agency Securities [Member] Inventory, Raw Materials, Gross Raw materials Cash, Cash Equivalents and Marketable Securities Cash, Cash Equivalent, and Marketable Security [Text Block] Total liabilities Liabilities Cost of sales Cost of Revenue Cost of Revenue, Total Product and Service [Axis] Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Ending Balance Accumulated deficit Cash and Cash Equivalents, Fair Value Disclosure Cash and Cash Equivalents Accounts payable Increase (Decrease) in Accounts Payable Increase (Decrease) in Accounts Payable, Total Revenues [Abstract] Revenue: Tranche A [Member] Tranche A. Vesting [Domain] Commercial Expenses Commercial expenses. Commercial expenses Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Stock shares issued during the period new issues shares Stock shares issued during the period shares Stock Issued During Period, Shares, New Issues Debt Issuance Costs Paid To Third Parties. Debt issuance costs paid to third parties. Debt issuance costs paid to third parties Exit Fees, Debt Issuance Costs The exit fees associated with debt issuance costs. Exit fees, debt issuance costs Variable Rate [Domain] Intangible Asset, Finite-Lived, Accumulated Amortization Accumulated Amortization Risk-free rate, Maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Cost of Sales, Vendor Allowances, Policy [Policy Text Block] Cost of Sales Total operating expenses Related party expense Operating Costs and Expenses Related Party Transactions [Abstract] Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones [Member] Achievement of specified worldwide aggregate annual net sales milestones. Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones [Member] Long-Term Debt [Text Block] Notes Payable Other Income Other expense, net Fair Value Hierarchy and NAV [Axis] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Product Information [Line Items] Inventory, Current [Table] Other financial statement information. Other Financial Statement Information [Abstract] Intangible Asset, Finite-Lived, Acquired, Weighted-Average Amortization Period Weighted-Average Remaining Life Corporate Debt Securities [Member] Corporate Debt Securities [Member] Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate Line of Credit Facility, Remaining Borrowing Capacity Remaining capacity available Debt Securities, Available-for-sale, Total Debt Securities, Available-for-Sale Fair value of the debt securities Estimated Fair Value Base Rate [Member] Base Rate [Member] Concentration Risk Type [Domain] Secured Debt, Total Secured Debt Collateralized note, Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average Grant date fair value Weighted Average Grant Date Fair Value, Beginning Balance Weighted Average Grant Date Fair Value, Ending Balance Customer [Domain] Two thousand and twenty four inducement plan. Two Thousand and Twenty Four Inducement Plan [Member] Two Thousand And Twenty Four Inducement Plan [Member] 2024 Inducement Plan [Member] Liabilities and Equity Total liabilities and stockholders' equity Accrued clinical trial costs Accrued Clinical Trial Costs Accrued clinical trial costs. Number of Options, Cancelled and forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares Research and development Research and Development Expense Research and Development Expense, Total Direct research and development Intangible Asset, Finite-Lived, Class [Axis] Document Fiscal Period Focus Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Accrued Royalties, Current Accrued royalties Subsegments [Domain] 2021 Loan Agreement [Member] Two Thousand Twenty One Loan Agreement [Member] Two thousand twenty one loan agreement. Intellectual Property [Member] Acquired intellectual property Agreement [Axis] Agreement Axis Grantee Status [Domain] Sale of Stock [Axis] Purchase Obligation, to be Paid, Remainder of Fiscal Year 2026 (remaining) IntegriChain [Member] IntegriChain. IntegriChain [Member] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Net decrease in cash and cash equivalents Entity Current Reporting Status Use of Estimates Use of Estimates, Policy [Policy Text Block] Number of Options, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Percentage of original contractual exit fee on old debt Percentage Of Original Contractual Exit Fee On Old Debt Percentage of original contractual exit fee on old debt. Customer One [Member] Customer one. Fair Value, Inputs, Level 1 [Member] Level 1 Class of Stock [Domain] Class of Stock [Domain] Accounts payable Accounts Payable, Current Accounts Payable, Current, Total Investment Type [Axis] Summary of Dilutive Shares Excluded From Computation of Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Financial Instrument [Axis] Document Transition Report Commitments and Contingencies Commitments and Contingencies Disclosure [Abstract] Increase (Decrease) in Inventories Increase (Decrease) in Inventories, Total Inventory Current liabilities: Liabilities, Current [Abstract] Prepayment Fee Percentage Year Three Prepayment fee percentage year three. Prepayment fee percentage year three Cash equivalents and marketable securities. Cash Equivalents and Marketable Securities [Member] Cash Equivalents And Marketable Securities [Member] Share-Based Payment Arrangement [Abstract] Cash [Member] Cash [Member] Common Stock [Member] Common Stock [Member] Credit Facility [Domain] Statistical Measurement [Domain] Marketable Securities, Total Marketable Securities Marketable Securities Sean Grant [Member] Sean Grant. Sean Grant [Member] Other income (expense): Nonoperating Income (Expense) [Abstract] Notes Payable Total borrowings Intangible Asset, Finite-Lived, before Accumulated Amortization Intangible Asset, Finite-Lived, before Accumulated Amortization, Total Gross Carrying Amount Stockholders' equity Equity, Attributable to Parent [Abstract] Weighted-average shares used in computing net loss per share attributable to common stockholders, basic Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Basic, Total Assets Assets [Abstract] Entity Central Index Key Antidilutive Securities [Axis] Aggregate Intrinsic Value, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Class of Stock [Line Item] Class Of Stock [Line Items] Other Liabilities, Current Related party payable amount Nature of Operation, Product Information, Concentration of Risk [Table] Consolidation Items [Axis] Current Fiscal Year End Date Increase (Decrease) in Accrued Liabilities Increase (Decrease) in Accrued Liabilities, Total Accrued and other liabilities Document Quarterly Report Long-Term Debt, Maturity, Remainder of Fiscal Year 2026 (remaining) Fair Value, Inputs, Level 2 [Member] Level 2 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted-Average Exercise Price, Opening balance Weighted Average Exercise Price, Ending balance Unrealized Gain (Loss) on Investments, Total Unrealized Gain (Loss) on Investments Change in unrealized gains and losses on marketable securities Two Thousand Twenty Five Loan Agreement [Member] Two thousand twenty five loan agreement. 2025 Loan Agreement [Member] Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block] Recently issued accounting pronouncements not yet adopted. Recently Issued Accounting Pronouncements Not Yet Adopted Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Entity Incorporation, State or Country Code Net loss per share attributable to common stockholders, diluted Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Preferred stock par or stated value per share Preferred Stock, Par or Stated Value Per Share Preferred stock, par value Net loss Net loss Segment and consolidated net loss Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Unaudited Interim Condensed Financial Statements [Policy Text Block] Unaudited interim condensed financial statements. Unaudited Condensed Financial Statements Collateralized note two thousand twenty three - twelve [Member] Collateralized Note Two Thousand Twenty Three - Twelve [Member] Collateralized note 2023-12 License Agreement License agreement. License agreement Revenue Recognition, Deferred Revenue [Policy Text Block] Product Revenue, Net Market Capitalization Threshold Amount Invalidating The Liquidity Covenant Market capitalization threshold amount which invalidates liquidity covenant upon condition. Market capitalization threshold amount invalidating liquidity covenant Equity Components [Axis] Collateralized debt instrument maturity date. Collateralized Debt Instrument Maturity Date Collateralized debt instrument maturity date Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Statement of Cash Flows [Abstract] 2021 Equity Incentive Plan [Member] Two Thousand and Twenty One Equity Incentive Plan [Member] Two Thousand and Twenty One Equity Incentive Plan [Member] Fair Value Hierarchy and NAV [Domain] Total marketable securities Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share based compensation arrangement by share based payment award, Options granted in period, Weighted average grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Prepaid expense and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Prepaid Expense and Other Assets, Total Share-Based Payment Arrangement, Nonemployee [Member] Non-employees [Member] Restricted cash [Member] Restricted Cash [Member] Restricted Cash [Member] Depreciation and amortization Depreciation, Depletion and Amortization Depreciation, Depletion and Amortization, Total Unrecorded Unconditional Purchase Obligations Disclosure [Table Text Block] Schedule of Minimum Purchase Obligations Collateralized Note Two Thousand Twenty Five Zero Six [Member] Collateralized note two thousand twenty five - zero six. Collateralized note 2025-06 Preferred stock shares authorized Preferred Stock, Shares Authorized Segment Reporting, Other Segment Item, Composition, Description Other segment items composition description Class of Stock [Axis] Class of Stock [Axis] Antidilutive Securities Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Counterparty Name [Axis] Follow On Public Offering [Member] Follow On Public Offering [Member] Follow-on Public Offering [Member] AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income/(Loss) [Member] Accumulated Other Comprehensive Income (Loss) [Member] Share-based compensation arrangement by share-based payment award, Number of shares available for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Shares available for future issuance Reclassifications [Policy Text Block] Reclassifications. Reclassifications Purchase Commitment, Remaining Minimum Amount Committed Total minimum purchase obligations Inventory Inventory, Net Inventory, Net, Total Loss Contingency, Estimate of Possible Loss Estimated loss Concentration Risk Benchmark [Domain] Interest Receivable Interest income receivable Customer Two [Member] Customer two. Total accrued expenses and other current liabilities Accrued Liabilities, Current Accrued expenses and other liabilities, current Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of Options, Beginning Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Number of Options, Ending Customer [Axis] Inventory, Work in Process, Gross Work in process Document Type Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Liabilities and Equity [Abstract] Liabilities and stockholders' equity Employee Stock Option [Member] Subsequent Event [Member] Subsequent Event [Member] Loss from operations Operating Income (Loss) Loss from operations Sale of stock, price per share Sale of Stock, Price Per Share Licenses Licenses [Text Block] Licenses. Prepayment Fee Percentage First Two Years Prepayment fee percentage first two years. Prepayment fee percentage first two years Segment Reporting [Table] Inventory, Gross Total inventory Asset Class [Domain] Thereafter Intangible Asset Finite Lived Estimated Amortization Expense After Year Four Intangible asset finite lived estimated amortization expense after year four Entity File Number TRUTAKNA [Member] TRUTAKNA. TRUTAKNA [Member] Inventory, Finished Goods, Gross Finished goods License Issue Fees Amount License issue fees amount. License issue fees Location, Statement of Income, Balance [Axis] Shares Reserved for ESPP Purchases [Member] Shares reserved for ESPP purchases. Shares Reserved For ESPP Purchases Risk-free rate, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Accumulated Deficit [Member] Retained Earnings [Member] Employees [Member] Share-Based Payment Arrangement, Employee [Member] Entity Registrant Name Accounting Policies [Abstract] Two Individual Customers [Member] Two individual customers. Selling, General and Administrative Expense Selling, General and Administrative Expense, Total Selling, general and administrative Accretion Of Loan Exit Fee And Amortization Of Loan Costs Accretion of loan exit fee and amortization of loan costs. Accretion of loan exit fee and amortization of loan costs Percentage of Old Debt Exit Fee Waived in Connection With The Refinancing Percentage of old debt exit fee waived in connection with the refinancing. Percentage of old debt exit fee waived in connection with the refinancing Entity Address, Address Line One Number of Options, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Weighted Average Exercise Price, Option exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Total current assets Assets, Current Loss Contingencies [Line Items] Class of Stock Disclosures [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Entity Small Business Aggregate Intrinsic Value, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Accrued Exit Fees Net of Unamortized Issuance Costs Accrued exit fees net of unamortized issuance costs. Accrued exit fees net of unamortized issuance costs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Cancelled and Forfeited Significant Accounting Policies [Text Block] Significant Accounting Policies Net Proceeds From Refinancing Under Loan and Security Agreement Net of Costs Net proceeds from refinancing under loan and security agreement net of costs. Proceeds from refinancing under loan and security agreement, net Regulatory Approval In The U S [Member] Regulatory Approval In The U.S [Member] regulatory approval in the U.S. Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable, net Consolidation Items [Domain] Accrued payroll Employee-related Liabilities, Current Employee-related Liabilities, Current, Total Tranche E [Member] Tranche E. Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Other Financial Statement Information Other Financial Statement Information [Text Block] Other Financial Statement Information. Earnings Per Share [Abstract] Summary of Share-based Compensation Arrangements by Share-based Payment Award Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Plan Name [Axis] Subsequent Event Type [Axis] Product and Service [Domain] Equity [Text Block] Stockholders' Equity Common stock issued pursuant to underwriters option shares Common Stock Issued During Period Underwriters Option Shares Common stock issued during period underwriters option shares. Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Intangible assets, net Intangible Asset, Including Goodwill, after Accumulated Amortization Intangible Asset, Including Goodwill, after Accumulated Amortization, Total Class A Common Stock Options Issued and Outstanding Class A Common Stock Issued And Outstanding [Member] Class A common stock issued and outstanding. Term Loan [Member] Term Loan [Member] Term loan. Payroll and related Payroll and Related Expenses Payroll and related expenses. Entity Tax Identification Number Accounts Receivable [Member] Accounts Receivable, Net Accounts Receivable [Policy Text Block] Equity Component [Domain] Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive loss Entity Address, City or Town Intangible Asset, Finite-Lived [Line Items] Long-Term Debt, Maturity, Year One 2027 Share Based Payment Arrangement [Table] Share Based Payment Arrangement Table Entity Common Stock, Shares Outstanding Accrued Commercial Planning, Ssales and Marketing Expenses Accrued commercial planning, sales and marketing expenses. Accrued commercial planning, sales and marketing expenses Concentration Risk Type [Axis] Schedule of Debt [Table Text Block] Schedule of Notes Payable US Government Debt Securities [Member] U.S. Government Bonds [Member] Schedule Of Accrued And Other Current Liabilities [Table Text Block] Schedule Of Accrued And Other Current Liabilities Schedule of Accrued Expenses And Other Current Liabilities Milestone payments paid. Milestone Payments Paid Milestone payments paid Antidilutive Security, Excluded EPS Calculation [Table] Payments to Acquire Marketable Securities, Total Payments to Acquire Marketable Securities Purchase of marketable securities Debt issuance costs paid to noncurrent deferred financing costs Debt Issuance Costs Paid To Third Parties Allocated To Noncurrent Deferred Financing Costs Debt issuance costs paid to third parties allocated to noncurrent deferred financing costs. Statement [Table] Amount withdrawn from the loan agreement Amount Withdrawn From The Loan Agrrement Amount withdrawn from the loan agreement. Stock-based compensation expense Share-based Payment Arrangement, Expense Share-Based Payment Arrangement, Expense Segment Reporting, Reconciliation of Profit (Loss) by Segment to Consolidated [Table Text Block] Schedule of Segment Operating Expenses Including Segment Expenses, and Net Loss Entity Shell Company Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash provided by (used in) investing activities Statement [Line Items] Software, Internally Developed [Member] Acquired internal-use software Common stock conversion basis Common Stock, Conversion Basis Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Maximum [Member] Maximum [Member] Sales discounts, rebates, and allowances Accrued Sales Discounts Rebates and Allowances Current Accrued sales discounts rebates and allowances current Debt Disclosure [Abstract] Sale of Stock [Domain] Interest income Investment Income, Interest Repurchase Agreement, Counterparty [Table] Tranche C Member. Tranche C [Member] Tranche C [Member] Amplyx Agreement [Member] Amplyx agreement member. Amplyx Agreement [Member] Event Event [Domain] Event [Domain] Schedule Of Share Based Payment Award Stock Options Valuation Assumptions [Table] Schedule Of Share Based Payment Award Stock Options Valuation Assumptions. Contract Manufacturing [Member] Contract Manufacturing [Member] Contract manufacturing. Concentration Risk Benchmark [Axis] Consolidation, Policy [Policy Text Block] Principles of Consolidation Agreement [Domain] Agreement Domain Stock-based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Asset Class [Axis] Investments, Debt and Equity Securities [Abstract] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Current assets: Assets, Current [Abstract] Marketable Securities [Line Items] Accretion of Discount and Amortization of Premium on Purchase of Debt Securities Accretion of discount and amortization of premium on purchase of debt securities. Accretion of discount and amortization of premium on purchase of debt securities Document Fiscal Year Focus Common stock, Shares outstanding Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding, Beginning Balance Common Stock, Shares, Outstanding, Ending Balance Line of Credit Exit Fee Percentage The percentage of exit fee payable on the aggregate principal amount of loan, in the event of default or prepayment. Line of credit exit fee percentage Due after one year to two years Available For Sale Securities Debt Maturities After One Through Two Years Fair Value Available for sale securities debt maturities after one through two years fair value. Financial Instruments [Domain] Related Party [Member] Related Party [Member] Ares Trading S A [Member] Ares Trading S A [Member] Ares Trading S A Member Entity Ex Transition Period Intangible Asset, Finite-Lived [Table Text Block] Other Accrued Liabilities, Current Other Additional paid-in capital Additional Paid in Capital, Common Stock Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Security Exchange Name Related and Nonrelated Parties [Axis] Recently Adopted Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Licenses [Abstract] Licenses. Entity Address, State or Province Share based compensation, Nonvested awards, Compensation cost not yet recognized period of recognition stock options and equity instruments other than options Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected volatility, Minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Schedule of Estimated Fair Value of Investments in Available-for-sale Marketable Debt Securities Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Net proceeds from this follow-on public offering Proceeds from Follow-on Public Offering Proceeds from Follow-on Public Offering Amendment Flag Loss Contingencies [Table] Summary of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity Stock Compensation Share-Based Payment Arrangement [Text Block] Concentration Risk, Percentage Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Debt Instrument [Axis] Debt Instrument [Axis] SOFR [Member] Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash and cash equivalents Debt instrument threshold amount invalidating liquidity covenant Debt Instrument Threshold Amount Invalidating Liquidity Covenant Debt instrument threshold amount which invalidates liquidity covenant upon condition. City Area Code Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones Reach Five Hundred Million [Member] Achievement of specified worldwide aggregate annual net sales milestones reach five hundred million. Achievement of Specified Worldwide Aggregate Annual Net Sales Milestones Reach Five Hundred Million [Member] Stock Issued During Period, Value, Employee Stock Purchase Plan Issuance of common stock pursuant to employee stock purchase plan, value Interest expense Interest Expense, Nonoperating, Total Interest Expense, Nonoperating Debt Principal Balance Of Collateralized Note Debt principal balance of collateralized note. Debt principal balance of collateralized note Percentage Of Prepayment Fee On Old Debt Waived In Connection With The Refinancing Percentage of prepayment fee on old debt waived in connection with the refinancing. Percentage of prepayment fee Accrued Drug Manufacturing Costs Accrued drug manufacturing costs. Accrued drug manufacturing costs Organization, Consolidation and Presentation of Financial Statements [Abstract] Debt Issuance Costs Paid To Third Parties Allocated To Other Nonoperating Expense Debt Issuance costs paid to third parties allocated to other nonoperating expense. Debt Issuance costs paid to third parties allocated to other nonoperating expense Operating expenses: Operating Expenses [Abstract] Milestone payments payable. Milestone Payments Payable Milestone payments payable Joseph Young [Member] Joseph Young [Member] Joseph Young. Common stock, Par value Common Stock, Par or Stated Value Per Share Common stock, par value Repurchase Agreement Counterparty [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options exercisable Number of Options, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Total current liabilities Liabilities, Current Marshall Fordyce, M.D. [Member] Marshall Fordyce, M.D. Marshall Fordyce [Member] Depreciation and amortization Depreciation, Amortization and Accretion, Net Depreciation, Amortization and Accretion, Net, Total Two Thousand And Seventeen EIP, Two Thousand And Twenty One EIP And Two Thousand And Twenty Four Inducement Plan[Member] Two Thousand And Seventeen EIP, Two Thousand And Twenty One EIP And Two Thousand And Twenty Four Inducement Plan. 2017 EIP, 2021 EIP and 2024 Inducement Plan [Member] Segment Reporting [Text Block] Segment Reporting Summarizes the Unrealized Gains and Losses in Fair Value of the Company's Investments in Debt Securities Debt Securities, Available-for-Sale [Table Text Block] Long-Term Debt, Maturity, Year Four 2030 Sale of Prelaunch Inventory, Costs Expensed in Prior Period Sale of prelaunch inventory, costs expensed in prior period. Sale of prelaunch inventory costs Trading Symbol Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Entity Emerging Growth Company Subsegments [Axis] Additional Paid-in Capital [Member] Cash Equivalents And Marketable Securities [Abstract] Cash equivalents and marketable securities abstract. Schedule of Prepaid Expenses and Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Two Thousand And Seventeen Equity incentive Plan [Member] Two thousand and seventeen equity incentive plan. 2017 Equity Incentive Plan [Member] Long-Term Debt, Gross Total long-term debt Carrying amount of debt outstanding Clinical Trials [Member] Clinical trials. Clinical Trials [Member] Plan Name [Domain] Other Liabilities, Noncurrent Other liabilities, noncurrent Common Class A [Member] Common Class A [Member] Stock Issued During Period, Shares, Employee Stock Purchase Plans Maximum number of shares authorized Issuance of common stock pursuant to employee stock purchase plan Share based compensation arrangement by share based payment award, Options exercised in period, Total intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Cover [Abstract] Segment Reporting, Other Segment Item, Amount Other segment items** Marketable Securities [Table] Summary of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Debt Securities, Available-for-Sale, Unrealized Gain (Loss) Debt Securities, Available-for-Sale, Unrealized Gain (Loss), Total Change in unrealized gains and losses on marketable securities Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive (loss) income Concentrations of Credit Risk and Other Risks and Uncertainties Concentration Risk, Credit Risk, Policy [Policy Text Block] Intangible Asset, Finite-Lived, Amortization Expense Intangible asset amortization expense Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Share-based Payment Arrangement, Noncash Expense, Total Tranche B. Tranche B [Member] Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash and cash equivalents Cash and Cash Equivalent Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash Employee Stock [Member] Employee Stock Purchase Plan [Member] Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Intangible Asset, Finite-Lived, Amortization Expense [Table Text Block] Debt Securities, Availablen for Sale, Gross Unrealized Gain Debt securities, available-for-sale, gross unrealized gain. Unrealized Gains Achievement Of Specified BLA Filing Or Regulatory Approval Milestones [Member] Achievement Of Specified BLA Filing Or Regulatory Approval Milestones [Member] Achievement Of Specified Bla Filing Or Regulatory Approval Milestones Member Entity Filer Category Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Marketable Securities, Current, Total Marketable Securities, Current Marketable securities Weighted Average Exercise Price, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Accounts receivable Increase (Decrease) in Accounts Receivable Intangible Asset, Finite-Lived, Estimated Amortization Expense, Year One 2027 Product revenue, net Revenue from Contract with Customer, Excluding Assessed Tax Upfront and Milestone Payments Under License Agreements Upfront and milestone payments under license agreements. Upfront and milestone payments under license agreements Ending Balances, shares Beginning balances, shares Shares, Outstanding Remaining Pre Launch Inventory Cost Remaining pre launch inventory cost Document Information [Line Items] Segment Reporting [Abstract] Other Other Assets, Current Entity Address, Postal Zip Code Statement of Financial Position [Abstract] Local Phone Number